Red
Brand Name(s):Remicade
Flixabi
Remsima
Inflectra
Zessly
Indication:Psoriasis
Rationale:1,2,3,8
Considered:May-07
Review Date:Feb-24
Comments:
MHRA -Drug Safety Update
Tumour necrosis factor alpha inhibitors: risk of tuberculosis further information at:
http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON404195
April 14